Process Development - Small Molecule: Market Size & Forecast 2026

The global small-molecule process development market sits at approximately USD 78.5B in 2025 (base year) and is on track to reach roughly USD 129B by 2032, compounding at a 7.4% CAGR over 2026-2032. The category covers the outsourced chemistry, scale-up, analytical, and tech-transfer services that innovators and generic manufacturers buy from contract development and manufacturing organizations (CDMOs) to move small-molecule drug substances from grams-in-the-lab to commercial batches. The market is structurally tighter than the broader pharma services market, because capacity additions lag API demand growth by 18-24 months and because oncology and CNS-pipeline molecules are getting harder to develop, demanding more iterative route scouting, more potent-ingredient containment, and more analytical cycles per program. > Synthesised from secondary and publicly verifiable sources via Claight

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.